# Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19

> **NCT04463420** · NA · UNKNOWN · sponsor: **Baqiyatallah Medical Sciences University** · enrollment: 224 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** PHR160 Spray
- **DRUG:** Placebo
- **DRUG:** Standard treatment

## Key facts

- **NCT ID:** NCT04463420
- **Lead sponsor:** Baqiyatallah Medical Sciences University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-15
- **Primary completion:** 2020-11-15
- **Final completion:** 2020-12-15
- **Target enrollment:** 224 (ESTIMATED)
- **Last updated:** 2020-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04463420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04463420, "Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04463420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*